Javascript must be enabled to continue!
The Effects of Methylprednisolone and Hyaluronic Acid on the Endometrium in Experimentally Induced Asherman Syndrome Rat Models: A Prospective Laboratory Study
View through CrossRef
Background and Objectives: The current study was designed as a prospective laboratory investigation to evaluate the histopathological effects and VEGF (vascular endothelial growth factor) expression in uterine tissue following treatment with a combination of methylprednisolone and hyaluronic acid in a rat model of experimentally induced Asherman Syndrome. Materials and Methods: Twenty-six female Sprague-Dawley rats were used. Trichloroacetic acid was applied to the right uterine horns of all the groups to induce adhesion formation. First, we induced the Asherman model in two rats (Group 1). The remaining rats were divided into the following three groups: Group 2 received intrauterine hyaluronic acid treatment, Group 3 received oral methylprednisolone treatment, and Group 4 received both treatments. Inflammation, gland count, and fibrosis levels were assessed histopathologically. VEGF levels were analyzed immunohistochemically. Results: Hyaluronic acid treatment increased the uterine lumen diameter and vascularization. Methylprednisolone treatment increased the gland count and uterine wall thickness while decreasing the inflammation and fibrosis scores. Combined treatment provided a statistically significant advantage over single treatments. In particular, the combined treatment group exhibited significantly lower fibrosis (p = 0.184) and inflammation scores (p = 0.071), as well as higher gland counts (p = 0.849) and VEGF expression (p = 0.114), compared to the groups receiving only methylprednisolone or hyaluronic acid. These differences indicate that the synergistic effect of the two agents results in more effective endometrial healing than when either treatment is applied alone. Conclusions: Methylprednisolone treatment significantly prevented adhesion formation and reduced the inflammation and fibrosis scores compared to hyaluronic acid treatment alone. The combined treatment adds to the effects of the hyaluronic acid treatment alone and provides better healing.
Title: The Effects of Methylprednisolone and Hyaluronic Acid on the Endometrium in Experimentally Induced Asherman Syndrome Rat Models: A Prospective Laboratory Study
Description:
Background and Objectives: The current study was designed as a prospective laboratory investigation to evaluate the histopathological effects and VEGF (vascular endothelial growth factor) expression in uterine tissue following treatment with a combination of methylprednisolone and hyaluronic acid in a rat model of experimentally induced Asherman Syndrome.
Materials and Methods: Twenty-six female Sprague-Dawley rats were used.
Trichloroacetic acid was applied to the right uterine horns of all the groups to induce adhesion formation.
First, we induced the Asherman model in two rats (Group 1).
The remaining rats were divided into the following three groups: Group 2 received intrauterine hyaluronic acid treatment, Group 3 received oral methylprednisolone treatment, and Group 4 received both treatments.
Inflammation, gland count, and fibrosis levels were assessed histopathologically.
VEGF levels were analyzed immunohistochemically.
Results: Hyaluronic acid treatment increased the uterine lumen diameter and vascularization.
Methylprednisolone treatment increased the gland count and uterine wall thickness while decreasing the inflammation and fibrosis scores.
Combined treatment provided a statistically significant advantage over single treatments.
In particular, the combined treatment group exhibited significantly lower fibrosis (p = 0.
184) and inflammation scores (p = 0.
071), as well as higher gland counts (p = 0.
849) and VEGF expression (p = 0.
114), compared to the groups receiving only methylprednisolone or hyaluronic acid.
These differences indicate that the synergistic effect of the two agents results in more effective endometrial healing than when either treatment is applied alone.
Conclusions: Methylprednisolone treatment significantly prevented adhesion formation and reduced the inflammation and fibrosis scores compared to hyaluronic acid treatment alone.
The combined treatment adds to the effects of the hyaluronic acid treatment alone and provides better healing.
Related Results
The Effects of Filgrastim and Hyaluronic acid on the Endometrium in Experimentally Induced Asherman Syndrome Rat Models: A Prospective Labrotory Study
The Effects of Filgrastim and Hyaluronic acid on the Endometrium in Experimentally Induced Asherman Syndrome Rat Models: A Prospective Labrotory Study
Background and Objectives: The aim of the present study was to explore the histopathological effects and tissue Vascular Endothelial Growth Factor (VEGF) levels of filgrastim and h...
Effects of Methylprednisolone and Hyaluronic Acid on the Endometrium in Experimentally Induced Asherman Syndrome Rat Models: A Prospective Laboratory Study
Effects of Methylprednisolone and Hyaluronic Acid on the Endometrium in Experimentally Induced Asherman Syndrome Rat Models: A Prospective Laboratory Study
Background and Objectives: This study aimed to evaluate the histopathological effects and tissue VEGF levels of combined methylprednisolone and hyaluronic acid treatment in a rat m...
A pilot and ex-vivo study of examination of endometrium tissue by catheter based optical coherence tomography
A pilot and ex-vivo study of examination of endometrium tissue by catheter based optical coherence tomography
Abstract
Objective
This study aimed to distinguish ex-vivo normal and abnormal endometrium tissue samples histologically by catheter based optical c...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
14th Annual Meeting, December 1980, Canberra1. Effect of dexamethasone on pineal β‐adrenoceptors. C. A. Maxwell, A. Foldes, N. T. Hinks and R. M. Hoskinson2. A clinicopathological ...
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract
Introduction
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1. The development of the prejunctional receptor hypothesis. M.W. McCulloch, M.J. Rand and D. F. Story2. Adrenoceptor‐ and cholinoceptor‐mediated modulation of transmitter release ...
Pulmonary Disorders After Injections of Hyaluronic Acid Fillers
Pulmonary Disorders After Injections of Hyaluronic Acid Fillers
Hyaluronic acid is chemically a repeating glycosaminoglycan (disaccharide of D- glucuronic acid and N-acetyl-D-glucosamine), the presence of which has been established in many huma...

